Dr. Agarwal’s Health Care Limited is set to make a significant entry into the stock market with its upcoming Initial Public Offering (IPO).
This move not only underscores the company’s growth trajectory but also highlights the expanding opportunities within India’s healthcare sector.
About the Company
Established in 1957, Dr. Agarwal’s Health Care Limited has evolved into a leading provider of comprehensive eye care services in India and Africa. With over 209 hospitals, including 165 in India and 15 globally, the company offers a range of services such as cataract and refractive surgeries.
In the six months leading up to September 30, 2024, the company treated 1.15 million patients and performed 140,787 surgeries. Backed by investors like TPG and Temasek, Dr. Agarwal’s holds a 25% market share in India’s eye care sector.
An Industry Overview
India’s healthcare industry is witnessing rapid growth, driven by increasing demand for quality medical services and technological advancements. The eye care segment, in particular, has seen significant expansion due to rising awareness about eye health and the prevalence of vision-related issues.
Companies like Dr. Agarwal’s are at the forefront, leveraging their extensive networks and expertise to cater to this growing demand.
IPO Complete Details
| Open Date | January 29, 2025 |
| Close Date | January 31, 2025 |
| Total Issue Size | ₹3,027.26 crores |
| Number of Shares | 7,53,04,970 shares |
| Price Band | ₹382 to ₹402 per share |
| Lot Size | 35 |
| Maximum Lot Size | 14 |
| Minimum Bid Price | ₹14,124 |
| Maximum Bid Price | ₹1,96,980 |
| Basis of Allotment | February 3, 2025 |
| Initiation of Refunds | February 4, 2025 |
| Credit of Shares to Demat Accounts | February 4, 2025 |
| Listing Date | February 5, 2025 |
| Listing Exchanges | BSE and NSE |
What Does This Mean For You?
For potential investors, this IPO presents an opportunity to invest in a well-established player in the eye care industry. The funds raised are expected to be utilized for debt reduction and expansion plans.
This includes a proposed merger with its listed subsidiary, Dr. Agarwal’s Eye Hospital, through a share swap within the next 12 months. This strategic move aims to streamline operations and enhance shareholder value.
Conclusion
Dr. Agarwal’s Health Care Limited’s upcoming IPO marks a pivotal moment in its growth journey. As the company seeks to expand its footprint and strengthen its financial position, this public offering provides an avenue for investors to be part of India’s burgeoning healthcare sector.
As always, it’s essential to review the company’s financials and consult with financial advisors before making investment decisions.
Want to apply for this IPO? Click here.
